Sort
85,873 grants matching “alzheimers”
A systems biology approach in Drosophila to identify novel factors that influence AD pathogenicity
$3,354,976Daniel Edward Lee Promislow · University Of Washington · RF1 · FY2017 · AG
Regulated cGAS activation in HSV-1-associated neuropathogenesis.
$3,354,022Pinghui Feng · University Of Southern California · RF1 · FY2025 · AG
Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks
$3,353,561Paul M Thompson · University Of Southern California · U01 · FY2024 · AG
Rush Alzheimer's Disease Core Center
$3,352,346David A Bennett · Rush University Medical Center · P30 · FY2018 · AG
Inflammation and Renin-Angiotensin System Dysfunction as risk factors for AD
$3,352,237Whitney Lee Wharton · Emory University · RF1 · FY2015 · AG
Understanding the complexity of gene dosage imbalance in Down syndrome
$3,352,210Stella T Chou · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
Next Generation Translational Proteomics for Alzheimer's and Related Dementias
$3,351,008Michael J Maccoss · University Of Washington · U19 · FY2020 · AG
Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study
$3,349,913Cecilia Sungmin Lee · University Of Washington · R01 · FY2020 · AG
Causes and Consequences of Healthcare Inequity in Alzheimer's Disease and Related Dementias
$3,343,572Amber E Barnato · Dartmouth College · P01 · FY2023 · AG
Multiple Approaches to Abeta Vaccination in Animal Models
$3,340,325Michael G Agadjanyan · Institute For Molecular Medicine · RF1 · FY2018 · AG
Project 1
$3,338,228Michael A Province · Washington University · U19 · FY2023 · AG
Small Molecule Ligands Targeting Pathological Tau Signaling In AD And Related Dementias
$3,336,256Scott Thomas Brady · University Of Illinois At Chicago · RF1 · FY2025 · AG
BRAIN CONNECTS: A Center for High-throughput Integrative Mouse Connectomics
$3,335,651Jeff W Lichtman · Harvard University · UM1 · FY2024 · NS
Microphysiological systems to Advance Precision medicine for Alzheimer's Disease and Related Dementias (MAP-AD)
$3,335,016Jason Stephen Meyer · Indiana University Indianapolis · U54 · FY2025 · AG
PET Radiopharmaceutical Sciences
$3,330,051Victor W Pike · National Institute Of Mental Health · ZIA · FY2011 · MH
Social inequalities and the onset of Alzheimer's pathology: The role of Race/Ethnicity, cognitive reserve, and occupational complexity
$3,327,587Sean Clouston · State University New York Stony Brook · RF1 · FY2019 · AG
National Alzheimer's Coordinating Center (NACC)
$3,327,380Walter A Kukull · University Of Washington · U01 · FY2010 · AG
Management of Hypertension among Persons with and without Dementia in Long-Term Care
$3,327,236Michelle Christina Odden · Stanford University · RF1 · FY2019 · AG
Humanin is an AD resilience factor through its interaction with APOE4
$3,327,055Pinchas Cohen · University Of Southern California · RF1 · FY2018 · AG
PREVENTABLE Vanguard Phase
$3,322,350Karen P Alexander · Duke University · U19 · FY2020 · AG
Project 1
$3,321,692Michael A Province · Washington University · U19 · FY2020 · AG
Flexible multivariate models for linking multi-scale connectome and genome data in Alzheimer's disease and related disorders
$3,319,889Vince D Calhoun · Georgia State University · RF1 · FY2019 · AG
NORTHWESTERN Alzheimer's Disease Research Center
$3,319,145Robert J Vassar · Northwestern University At Chicago · P30 · FY2021 · AG
Alzheimer's Disease Research Center
$3,318,934Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2020 · AG
Vanderbilt Memory & Aging Project
$3,318,775Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2025 · AG